218 related articles for article (PubMed ID: 33834491)
1. Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.
Stingeni L; Francisci D; Bianchi L; Hansel K; Tramontana M; Di Candilo F; Mannarino MR; Pirro M
Contact Dermatitis; 2021 Sep; 85(3):366-368. PubMed ID: 33834491
[No Abstract] [Full Text] [Related]
2. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test.
Salman A; Yucelten D; Akin Cakici O; Kepenekli Kadayifci E
Pediatr Dermatol; 2019 Jul; 36(4):514-516. PubMed ID: 31050838
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
5. Acute generalized exanthematous pustulosis induced by oxacillin confirmed by patch testing.
Gammoudi R; Ben Salem C; Boussofara L; Fathallah N; Ghariani N; Slim R; Sriha B; Belajouza C; Nouira R; Denguezli M
Contact Dermatitis; 2018 Aug; 79(2):108-110. PubMed ID: 29655194
[No Abstract] [Full Text] [Related]
6. Results of patch testing in acute generalized exanthematous pustulosis (AGEP): A literature review.
de Groot AC
Contact Dermatitis; 2022 Aug; 87(2):119-141. PubMed ID: 35187690
[TBL] [Abstract][Full Text] [Related]
7. AGEP sine pustulosis induced by hydroxychloroquine used for COVID-19 infection.
Demircioğlu D; Karabıyık N; Durmaz EÖ; Demirkesen C; Şahin S
Dermatol Ther; 2022 Mar; 35(3):e15263. PubMed ID: 34907646
[No Abstract] [Full Text] [Related]
8. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
[TBL] [Abstract][Full Text] [Related]
9. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
[No Abstract] [Full Text] [Related]
10. COVID-19 presenting as acute generalized exanthematous pustulosis associated with multiorgan dysfunction in a 44-year-old female patient.
Ordoñez NA; Sepulveda VG; Vargas LP; Moreno JM
Rev Inst Med Trop Sao Paulo; 2021; 63():e42. PubMed ID: 34037158
[TBL] [Abstract][Full Text] [Related]
11. Acute generalized exanthematous pustulosis x Von Zumbusch's pustular psoriasis: a diagnostic challenge in a psoriatic patient.
Sousa AS; Lara OA; Papaiordanou F; Marchioro GS; Tebcherani AJ
An Bras Dermatol; 2015; 90(4):557-60. PubMed ID: 26375226
[TBL] [Abstract][Full Text] [Related]
12. Acute generalized exanthematous pustulosis during the puerperal period: a case report.
Matsushita H; Ishiguro T; Kurabayashi T; Shibuya M
Clin Exp Obstet Gynecol; 2012; 39(3):414-6. PubMed ID: 23157063
[TBL] [Abstract][Full Text] [Related]
13. A case of acute generalized exanthematous pustulosis due to amoxicillin-clavulanate with multiple positivity to beta-lactam patch testing.
Bomarrito L; Zisa G; Delrosso G; Farinelli P; Galimberti M
Eur Ann Allergy Clin Immunol; 2013 Sep; 45(5):178-80. PubMed ID: 24129046
[TBL] [Abstract][Full Text] [Related]
14. Acute generalized exanthematous pustulosis due to nystatin confirmed by scratch patch test.
Couture-Lapointe C; Houle MC; Schreiber A
Contact Dermatitis; 2022 Feb; 86(2):138-139. PubMed ID: 34687056
[No Abstract] [Full Text] [Related]
15. Acute generalized exanthematous pustulosis (AGEP) induced by azithromycin.
Campanón-Toro MV; Sierra O; Moreno E; Sobrino-García M; Gracia-Bara MT; Dávila I
Contact Dermatitis; 2017 Jun; 76(6):363-364. PubMed ID: 28497632
[No Abstract] [Full Text] [Related]
16. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
[No Abstract] [Full Text] [Related]
17. A Case of Amoxicillin-Induced Acute Generalized Exanthematous Pustulosis Presenting as Septic Shock.
McDonald KA; Pierscianowski TA
J Cutan Med Surg; 2017; 21(4):351-355. PubMed ID: 28358593
[TBL] [Abstract][Full Text] [Related]
18. Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime.
Chaabane A; Aouam K; Gassab L; Njim L; Boughattas NA
Fundam Clin Pharmacol; 2010 Aug; 24(4):429-32. PubMed ID: 19925632
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous vasculitis overlap with acute generalised exanthematous pustulosis (AGEP).
Murad A; Murphy A
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25404248
[TBL] [Abstract][Full Text] [Related]
20. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
